Cargando…

The Effect of Upadacitinib on Lipid Profile and Cardiovascular Events: A Meta-Analysis of Randomized Controlled Trials

Background: Our aim was to systematically investigate the effect of upadacitinib, an oral JAK-1 selective inhibitor, on lipid profile and cardiovascular disease risk. Methods: PubMed, PubMed Central and ClinicalTrials.gov databases were searched for relevant randomized controlled trials (RCTs) up to...

Descripción completa

Detalles Bibliográficos
Autores principales: Makris, Anastasios, Barkas, Fotios, Sfikakis, Petros P., Liberopoulos, Evangelos, Agouridis, Aris P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740350/
https://www.ncbi.nlm.nih.gov/pubmed/36498468
http://dx.doi.org/10.3390/jcm11236894